Franklin European Quality Dividend vs TIN Ny Teknik

Franklin European Quality Dividend vs TIN Ny Teknik

1. Franklin European Quality Dividend

  • Security

    Franklin European Quality Dividend UCITS ETF

  • Fee

    0.30%

  • ISIN

    IE00BF2B0L69

  • Holdings

    21

2. TIN Ny Teknik

  • Security

    TIN Ny Teknik A

  • Fee

    1.50%

  • ISIN

    SE0012193019

  • Holdings

    10

Fund Holdings

We have information about 21 holdings in Franklin European Quality Dividend, where the largest holding is GlaxoSmithKline (3.51), followed by Bae Systems (3.43) and Hannover Rück (3.16). In comparison with TIN Ny Teknik, we have 10 holdings where Surgical Science is the largest holding (7.39), followed by Novo Nordisk (5.98) and ChemoMetec (5.92).

All Holdings

Here we compare the holdings in Franklin European Quality Dividend and TIN Ny Teknik.

Franklin European Quality Dividend TIN Ny Teknik
1. GlaxoSmithKline ADR
UK
3.51 %
1. Surgical Science Sweden AB
Sweden
7.39 %
2. Bae Systems PLC
UK
3.43 %
2. Novo Nordisk B
Denmark
5.98 %
3. Hannover Rück SE
Germany
3.16 %
3. ChemoMetec
Denmark
5.92 %
4. Allianz SE
Germany
3.12 %
4. Paradox Interactive AB
Sweden
5.85 %
5. Assicurazioni Generali SpA
Italy
3.12 %
5. Qt Group Plc
Finland
5.12 %
6. Gaztransport Et Technigaz SA
France
3.08 %
6. Epidemic Sound Holdings AB
Sweden
5.11 %
7. UPM-Kymmene Oyj
Finland
3.02 %
7. BioGaia B
Sweden
5.06 %
8. Zurich Insurance Group AG
Switzerland
2.99 %
8. Fortnox AB
Sweden
5.02 %
9. KPN NV
Netherlands
2.98 %
9. Evolution Gaming Group AB
Sweden
4.6 %
10. Snam SpA
Italy
2.96 %
10. Sectra B
Sweden
4.45 %
11. Swisscom AG
Switzerland
2.95 %
-
12. Sanofi SA
France
2.94 %
-
13. Imperial Brands Plc
UK
2.94 %
-
14. Admiral Group Plc
UK
2.92 %
-
15. Elisa Oyj
Finland
2.9 %
-
16. Iberdrola SA
Spain
2.88 %
-
17. Rio Tinto PLC
Australia UK
2.87 %
-
18. TotalEnergies SE
France
2.76 %
-
19. Telenor ASA
Norway
2.73 %
-
20. Tryg A/S
Denmark
2.47 %
-
21. Redeia Corporacion SA
Spain
2.46 %
-

The list of fund holdings was last updated on June 5, 2025.